DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Rosenfeld PJ, Schwartz SD, Blumenkranz MS. et al.
Safety of rhuFabV2, an anti-VEGF antibody fragment, as asingle intravitreal injection in patients with neovascular AMD.
Vitreous Society 2001; 121-122
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.